Skip to content

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

About
Science
- Overview
- Publications
Pipeline
Investors
Careers
Contact

Press Releases

Choose Year
Search Press Releases

Found 86 Results

August 8, 2025

Surrozen Reports Second Quarter 2025 Financial Results and Provides Business Update

August 6, 2025

Surrozen to Present at Upcoming Healthcare Investor Conference

May 14, 2025

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

May 9, 2025

Surrozen Reports First Quarter 2025 Financial Results and Provides Business Update

March 31, 2025

Surrozen Provides Fourth Quarter and Full Year 2024 Financial Results and Business Updates

March 24, 2025

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases

November 6, 2024

Surrozen to Present at Upcoming Healthcare Investor Conferences

November 6, 2024

Surrozen Provides Third Quarter 2024 Financial Results and Business Update

November 4, 2024

Surrozen and TCGFB,Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis

September 24, 2024

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration

«123 4 5...»

IR Contact

Email: investorinfo@surrozen.com

Email Alerts Sign-Up

Email

Unsubscribe

Loading...

Company

About
Management
Board of Directors
Scientific Advisors
Contact
Careers

Science

Science
Pipeline
Publications

Investors

Overview
News
Events
SEC Filings
Corporate Governance
Stock Information
FAQs

Copyright © 2026 Surrozen. All Rights Reserved

FCOI Policy
Accessibility

Scroll to Top